117 related articles for article (PubMed ID: 27470985)
1. Unique proteome signature of post-chemotherapy ovarian cancer ascites-derived tumor cells.
Ahmed N; Greening D; Samardzija C; Escalona RM; Chen M; Findlay JK; Kannourakis G
Sci Rep; 2016 Jul; 6():30061. PubMed ID: 27470985
[TBL] [Abstract][Full Text] [Related]
2. Emerging perspectives on growth factor metabolic relationships in the ovarian cancer ascites environment.
Monavarian M; Elhaw AT; Tang PW; Javed Z; Shonibare Z; Scalise CB; Arend R; Jolly MK; Sewell-Loftin MK; Hempel N; Mythreye K
Semin Cancer Biol; 2022 Nov; 86(Pt 2):709-719. PubMed ID: 35259492
[TBL] [Abstract][Full Text] [Related]
3. Disruption of sugar nucleotide clearance is a therapeutic vulnerability of cancer cells.
Doshi MB; Lee N; Tseyang T; Ponomarova O; Goel HL; Spears M; Li R; Zhu LJ; Ashwood C; Simin K; Jang C; Mercurio AM; Walhout AJM; Spinelli JB; Kim D
Nature; 2023 Nov; 623(7987):625-632. PubMed ID: 37880368
[TBL] [Abstract][Full Text] [Related]
4. Chemoresistant Cancer Cell Lines Are Characterized by Migratory, Amino Acid Metabolism, Protein Catabolism and IFN1 Signalling Perturbations.
Acland M; Lokman NA; Young C; Anderson D; Condina M; Desire C; Noye TM; Wang W; Ricciardelli C; Creek DJ; Oehler MK; Hoffmann P; Klingler-Hoffmann M
Cancers (Basel); 2022 Jun; 14(11):. PubMed ID: 35681748
[TBL] [Abstract][Full Text] [Related]
5. Select Per- and Polyfluoroalkyl Substances (PFAS) Induce Resistance to Carboplatin in Ovarian Cancer Cell Lines.
Rickard BP; Tan X; Fenton SE; Rizvi I
Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563566
[TBL] [Abstract][Full Text] [Related]
6. Prognostic utility of the ovarian cancer secretome: a systematic investigation.
Kamble PR; Breed AA; Pawar A; Kasle G; Pathak BR
Arch Gynecol Obstet; 2022 Sep; 306(3):639-662. PubMed ID: 35083554
[TBL] [Abstract][Full Text] [Related]
7. Expression of TIMPs and MMPs in Ovarian Tumors, Ascites, Ascites-Derived Cells, and Cancer Cell Lines: Characteristic Modulatory Response Before and After Chemotherapy Treatment.
Escalona RM; Kannourakis G; Findlay JK; Ahmed N
Front Oncol; 2021; 11():796588. PubMed ID: 35047406
[TBL] [Abstract][Full Text] [Related]
8. A transcriptional biosensor to monitor single cancer cell therapeutic responses by bioluminescence microscopy.
Champagne A; Jain P; Vélot L; Riopel J; Lefebvre V; Neveu B; Pouliot F
Theranostics; 2022; 12(2):474-492. PubMed ID: 34976196
[TBL] [Abstract][Full Text] [Related]
9. Clinical Significance of Screening Differential Metabolites in Ovarian Cancer Tissue and Ascites by LC/MS.
Liu M; Liu Y; Feng H; Jing Y; Zhao S; Yang S; Zhang N; Jin S; Li Y; Weng M; Xue X; Wang F; Yang Y; Jin X; Kong D
Front Pharmacol; 2021; 12():701487. PubMed ID: 34795577
[TBL] [Abstract][Full Text] [Related]
10. Capturing tumour heterogeneity in pre- and post-chemotherapy colorectal cancer ascites-derived cells using single-cell RNA-sequencing.
Poonpanichakul T; Shiao MS; Jiravejchakul N; Matangkasombut P; Sirachainan E; Charoensawan V; Jinawath N
Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34708245
[TBL] [Abstract][Full Text] [Related]
11. Plectin in Cancer: From Biomarker to Therapeutic Target.
Perez SM; Brinton LT; Kelly KA
Cells; 2021 Aug; 10(9):. PubMed ID: 34571895
[TBL] [Abstract][Full Text] [Related]
12. Malignant Ascites in Ovarian Cancer: Cellular, Acellular, and Biophysical Determinants of Molecular Characteristics and Therapy Response.
Rickard BP; Conrad C; Sorrin AJ; Ruhi MK; Reader JC; Huang SA; Franco W; Scarcelli G; Polacheck WJ; Roque DM; Del Carmen MG; Huang HC; Demirci U; Rizvi I
Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503128
[TBL] [Abstract][Full Text] [Related]
13. The attributes of plakins in cancer and disease: perspectives on ovarian cancer progression, chemoresistance and recurrence.
Wesley T; Berzins S; Kannourakis G; Ahmed N
Cell Commun Signal; 2021 May; 19(1):55. PubMed ID: 34001250
[TBL] [Abstract][Full Text] [Related]
14. Human METTL7B is an alkyl thiol methyltransferase that metabolizes hydrogen sulfide and captopril.
Maldonato BJ; Russell DA; Totah RA
Sci Rep; 2021 Mar; 11(1):4857. PubMed ID: 33649426
[TBL] [Abstract][Full Text] [Related]
15. TIMP-2 regulates proliferation, invasion and STAT3-mediated cancer stem cell-dependent chemoresistance in ovarian cancer cells.
Escalona RM; Bilandzic M; Western P; Kadife E; Kannourakis G; Findlay JK; Ahmed N
BMC Cancer; 2020 Oct; 20(1):960. PubMed ID: 33023532
[TBL] [Abstract][Full Text] [Related]
16. Signaling within the epithelial ovarian cancer tumor microenvironment: the challenge of tumor heterogeneity.
Horowitz M; Esakov E; Rose P; Reizes O
Ann Transl Med; 2020 Jul; 8(14):905. PubMed ID: 32793749
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in mass spectrometry based clinical proteomics: applications to cancer research.
Macklin A; Khan S; Kislinger T
Clin Proteomics; 2020; 17():17. PubMed ID: 32489335
[TBL] [Abstract][Full Text] [Related]
18. Flow-induced Shear Stress Confers Resistance to Carboplatin in an Adherent Three-Dimensional Model for Ovarian Cancer: A Role for EGFR-Targeted Photoimmunotherapy Informed by Physical Stress.
Nath S; Pigula M; Khan AP; Hanna W; Ruhi MK; Dehkordy FM; Pushpavanam K; Rege K; Moore K; Tsujita Y; Conrad C; Inci F; Carmen MGD; Franco W; Celli JP; Demirci U; Hasan T; Huang HC; Rizvi I
J Clin Med; 2020 Mar; 9(4):. PubMed ID: 32231055
[TBL] [Abstract][Full Text] [Related]
19. Ovarian Cancer, Cancer Stem Cells and Current Treatment Strategies: A Potential Role of Magmas in the Current Treatment Methods.
Ahmed N; Kadife E; Raza A; Short M; Jubinsky PT; Kannourakis G
Cells; 2020 Mar; 9(3):. PubMed ID: 32183385
[TBL] [Abstract][Full Text] [Related]
20. Liquid Biopsies for Ovarian Carcinoma: How Blood Tests May Improve the Clinical Management of a Deadly Disease.
Mari R; Mamessier E; Lambaudie E; Provansal M; Birnbaum D; Bertucci F; Sabatier R
Cancers (Basel); 2019 Jun; 11(6):. PubMed ID: 31167492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
